References
- Azuma H, Miyasaka K, Yokotani T, Tachibana T, Kojima-Yuasa A, Matsui-Yuasa I, Ogino K (2006): Lipase-catalyzed preparation of optically active 1′-acetoxychavicol acetates and their structure-activity relationships in apoptotic activity against human leukemia HL-60 cells. Bioorg Med Chem 14: 1811–1818.
- Campbell CT, Prince M, Landry GM, Kha V, Kleiner HE (2007): Pro-apoptotic effects of 1′-acetoxychavicol acetate in human breast carcinoma cells. Toxicol Lett 173: 151–160.
- Farnsworth NR, Bunyapraphatsara N (1992): Thai Medicinal Plants: Recommended for Primary Health Care System. Bangkok, Prachachon, pp. 1–217.
- Ito K, Nakazato T, Xian MJ, Yamada T, Hozumi N, Murakami A, Ohigashi H, Ikeda Y, Kizaki M (2005): 1′-Acetoxychavicol acetate is a novel nuclear factor κB inhibitor with significant activity against multiple myeloma in vitro and in vivo. Cancer Res 65: 4417–4424.
- Itokawa H, Morita H, Sumitomo T, Totsuka N, Takeya K (1987): Antitumor principles from Alpinia galangal. Planta Med 53: 32–33.
- Janssen AM, Scheffer JJC (1985): Acetoxychavicol acetate, an antifungal component of Alpinia galanga. Planta Med 51: 507–511.
- Kondo A, Ohigashi H, Murakami A, Suratwadee J, Koshimitzu K (1993): 1′-Acetoxychavicol acetate as a potent inhibitor of tumor promoter-induced Epstein-Barr virus activation from Laguas galanga, a traditional Thai condiment. Biosci Biotechnol Biochem 57: 1344–1345.
- Kubota K, Ueda Y, Yasuda M, Masuda A (2001): Occurrence and antioxidative activity of 1′-acetoxychavicol acetate and its related compounds in the rhizomes of Alpinia galanga during cooking. Spec Publ R Soc Chem 274: 601–607.
- Moffatt J, Hashimoto M, Kojima A, Kennedy DO, Murakami A, Koshimizu K, Ohigashi H, Matsui-Yuasa I (2000): Apoptosis induced by 1′-acetoxychavicol acetate in Ehrlich ascites tumor cells is associated with modulation of polyamine metabolism and caspase-3 activation. Carcinogenesis 21: 2151–2157.
- Morikawa T, Ando S, Matsuda H, Kataoka S, Muraoka O, Yoshikawa M (2005): Inhibitors of nitric oxide production from the rhizomes of Alpinia galanga: Structures of new 8-9′ linked neolignans and sesquineolignan. Chem Pharm Bull 53: 625–630.
- Nakamura Y, Murakami A, Ohto Y, Torikai K, Tanaka T, Ohigashi H (1998): Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 1′-acetoxychavicol acetate. Cancer Res 58: 4832–4839.
- NCCLS (2008): Performance Standards for Antimicrobial Susceptibility Testing; Ninth Informational Supplement. NCCLS document M100-S9. Wayne, PA, National Committee for Clinical Laboratory Standard, pp. 120–126.
- Noro T, Sekiya T, Katoh M, Oda Y, Miyase T, Kuroyanagi M, Ueno A, Fukushima S (1988): Inhibitors of xanthine oxidase from Alpinia galanga. Chem Pharm Bull 36: 244–248.
- Oonmetta-aree J, Suzuki T, Gasaluck P, Eumkeb G (2006): Antimicrobial properties and action of galangal (Alpinia galanga Linn.) on Staphylococcus aureus. LWT Food Sci Technol 39: 1214–1220.
- Swanson IK (2003): Antibiotic resistance of Propionibacterium acnes in Acnes vulgaris. Dermatol Nurs 5: 359–361.
- Ye Y, Li B (2006): 1′ S-1′-Acetoxychavicol acetate isolated from Alpinia galanga inhibits human immunodeficiency virus type 1 replication by blocking Rev transport. J Gen Virol 87: 2047–2053.
- Zheng Q, Hirose Y, Yoshimi N, Murakami A, Koshimizu K, Ohigashi H, Sakata K, Matsumoto Y, Sayama Y, Mori H (2002): Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cell. J Cancer Res Cli Oncol 128: 539–546.